Recent advance in tuberous sclerosis related epilepsy treated by cannabinol

VernacularTitle:大麻二酚治疗结节性硬化症所致癫痫的研究进展
Author: Fei JIAO ¹ ; Juan SUN ; Langui WANG
Author Information

1. 青海大学研究生院，西宁　810000
Keywords: Cannabinoid; Tuberous sclerosis; Epilepsy; Efficacy; Safety
From: Chinese Journal of Neuromedicine 2023;22(4):418-421
CountryChina
Language:Chinese
Abstract: Cannabinoid has attracted extensive attention in recent years, and its medicinal potentials have been gradually explored. Cannabinoid has been approved for Dravet syndrome and Lennox Gastaut syndrome by United States Food and Drug Administration. Recent research shows that cannabinoid is also applicable to tuberous sclerosis related epilepsy. This article reviews the history, mechanism, efficacy and safety of cannabinoid in treating tuberous sclerosis related epilepsy, and interactions between cannabinoid and other antiepileptic drugs so as to provide ideas for tuberous sclerosis related epilepsy.